![](https://skynews.icu/wp-content/uploads/2024/05/Food-Keto-Diet-Text.jpg)
![Food Keto Diet Text](https://skynews.icu/wp-content/uploads/2024/05/Can-Taking-Breaks-Enhance-the-Benefits-of-a-Keto-Diet.jpg)
A study from UC Davis shows that a ketogenic diet delays early-stage Alzheimer’s in mice by enhancing memory and cognitive functions through increased levels of beta-hydroxybutyrate (BHB). This could offer insights into managing mild cognitive impairment in humans.
UC Davis research indicates that a ketogenic diet could delay early Alzheimer’s symptoms in mice by boosting beta-hydroxybutyrate levels, improving memory and cognitive functions.
The ketogenic diet is a low-carbohydrate, high-fat, and moderate protein diet, which shifts the body’s metabolism from using glucose as the main fuel source to burning fat and producing ketones for energy. Previously, UC Davis researchers discovered that mice lived 13% longer on ketogenic diets.
In a new study, which follows up on their previous research, they found that a ketogenic diet significantly delays the early stages of Alzheimer’s-related memory loss in mice. This early memory loss is comparable to mild cognitive impairment in humans that precedes full-blown Alzheimer’s disease. Their findings were recently published in the Nature Group journal Communications Biology.
Key Findings on Alzheimer’s and Ketogenesis
The researchers found that the molecule beta-hydroxybutyrate, or BHB, plays a pivotal role in preventing early memory decline. It increases almost sevenfold on the ketogenic diet.
“The data support the idea that the ketogenic diet in general, and BHB specifically, delays mild cognitive impairment and it may delay full blown Alzheimer’s disease,” said co-corresponding author Gino Cortopassi, a biochemist and pharmacologist with the UC Davis School of Veterinary Medicine. “The data clearly don’t support the idea that this is eliminating Alzheimer’s disease entirely.”
![Keto Diet Prevents Early Memory Decline in Mice](https://skynews.icu/wp-content/uploads/2024/07/Groundbreaking-Study-Links-Keto-Diet-to-Reduced-Memory-Loss.jpg)
A molecule found in the keto diet plays a key role in preventing early memory decline in mice. The memory loss is comparable to mild cognitive impairment in the early stages of Alzheimer’s disease in humans. Credit: UC Davis School of Veterinary Medicine
Benefits of BHB in Cognitive Function
Scientists gave mice enough BHB to simulate the benefits of being on the keto diet for seven months.
“We observed amazing abilities of BHB to improve the function of synapses, small structures that connect all nerve cells in the brain. When nerve cells are better connected, the memory problems in mild cognitive impairment are improved,” said co-corresponding author Izumi Maezawa, professor of pathology at the UC Davis School of Medicine.
Cortopassi noted that BHB is also available as a supplement for humans. He said a BHB supplement could likely support memory in mice, but that hasn’t yet been shown.
Gender-Specific Responses and Future Research
Researchers found that the ketogenic diet mice exhibited significant increases in the biochemical pathways related to memory formation. The keto diet also seemed to benefit females more than males and resulted in higher levels of BHB in females.
“If these results translated to humans, that could be interesting since females, especially those bearing the ApoE4 gene variant, are at significantly higher risk for Alzheimer’s,” Cortopassi said.
The research team is optimistic about the potential impact on healthy aging and plans to delve further into the subject with future studies.
Reference: “Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer’s mouse model and stimulates synaptic plasticity pathway enzymes” by Jacopo Di Lucente, Giuseppe Persico, Zeyu Zhou, Lee-Way Jin, Jon J. Ramsey, Jennifer M. Rutkowsky, Claire M. Montgomery, Alexey Tomilov, Kyoungmi Kim, Marco Giorgio, Izumi Maezawa and Gino A. Cortopassi, 16 February 2024, Communications Biology.
DOI: 10.1038/s42003-024-05860-z
Funding: The study was funded by the National Institute on Aging, a unit of the National Institutes of Health.